MedTech
Why Robinhood?
You can watch MedTech and buy or sell other stocks, ETFs, and their options commission-free!About MTAC
TriSalus Life Sciences, Inc. is an oncology company, which engages in the business of integrating standard-of-care treatments and investigational immunotherapeutic with disruptive pressure enabled drug delivery infusion systems to transform the treatment paradigm for patients battling liver and pancreatic tumors. The company was founded on September 11, 2020 and is headquartered in Westminster, CO.
MTAC Key Statistics
Stock Snapshot
With a market cap of 232.49M, MedTech(MTAC) trades at $4.65. The stock has a price-to-earnings ratio of -2.54.
During the trading day, MedTech(MTAC) stock saw an opening price of —, a peak of —, and a bottom of —.
Trading volume for MedTech(MTAC) stock has reached 0, versus its average volume of 170.78K.
Over the past 52 weeks, MedTech(MTAC) stock has traded between a high of $7.95 and a low of $3.42.
Over the past 52 weeks, MedTech(MTAC) stock has traded between a high of $7.95 and a low of $3.42.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.